512 related articles for article (PubMed ID: 23706417)
21. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
Pan YQ; Zhang X; Xu DP; Bao WG; Lin AF; Xu HH; Yan WH
Neoplasma; 2014; 61(4):468-75. PubMed ID: 24712846
[TBL] [Abstract][Full Text] [Related]
22. Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients.
Werynska B; Pula B; Muszczynska-Bernhard B; Gomulkiewicz A; Piotrowska A; Prus R; Podhorska-Okolow M; Jankowska R; Dziegiel P
Exp Mol Pathol; 2013 Feb; 94(1):301-8. PubMed ID: 23064051
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of BCL6 corepressor-like 1 in non-small cell lung cancer].
Zhao X; Tuo H; Si M; Wang L; Liang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1677-81. PubMed ID: 26648304
[TBL] [Abstract][Full Text] [Related]
25. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
Chang C; Wang P; Yang H; Li L; Zhang LB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
[TBL] [Abstract][Full Text] [Related]
26. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
29. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
[TBL] [Abstract][Full Text] [Related]
30. Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer.
Yang X; Zhang Z; Qiu M; Hu J; Fan X; Wang J; Xu L; Yin R
Cancer Lett; 2013 Dec; 341(2):265-73. PubMed ID: 23962560
[TBL] [Abstract][Full Text] [Related]
31. [Effect of the intercellular adhesion molecule E-cadherin on the prognosis of non-small cell lung cancer].
Kolesnik AP; Shevchenko AI; Tumanskiĭ VA; Evseev AV
Arkh Patol; 2013; 75(5):30-3. PubMed ID: 24341230
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
33. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
34. High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancer.
Bai XY; Lin JY; Zhang XC; Xie Z; Yan HH; Chen ZH; Xu CR; An SJ; Sheng GM; Wu YL
Cancer Biomark; 2013; 13(1):37-47. PubMed ID: 23736020
[TBL] [Abstract][Full Text] [Related]
35. USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma.
Zhao GY; Lin ZW; Lu CL; Gu J; Yuan YF; Xu FK; Liu RH; Ge D; Ding JY
Tumour Biol; 2015 Mar; 36(3):1721-9. PubMed ID: 25519684
[TBL] [Abstract][Full Text] [Related]
36. [Expression of ERCC1 mRNA and its impact on the prognosis of patients with non-small cell lung cancer].
Ma W; Li W; Gao M; Li XN
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):371-4. PubMed ID: 21875468
[TBL] [Abstract][Full Text] [Related]
37. Reversed expression of GRIM-1 and GRP78 in human non-small cell lung cancer.
Wu HM; Jiang ZF; Fan XY; Wang T; Ke-Xu ; Yan XB; Ma Y; Xiao WH; Liu RY
Hum Pathol; 2014 Sep; 45(9):1936-43. PubMed ID: 25081541
[TBL] [Abstract][Full Text] [Related]
38. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
39. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.
Müller-Tidow C; Metzger R; Kügler K; Diederichs S; Idos G; Thomas M; Dockhorn-Dworniczak B; Schneider PM; Koeffler HP; Berdel WE; Serve H
Cancer Res; 2001 Jan; 61(2):647-53. PubMed ID: 11212263
[TBL] [Abstract][Full Text] [Related]
40. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E
Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]